...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: OTC Expert & Grey Market Restrictions

This new rule really sucks.  Is there any other way to look at it but to concede that ZHCLF will be delisted?  And become completely unlisted anywhere and not at all tradeable / liquidateable?

The only way around it that I can see would be if Zenith decides to start meeting the reporting requirements of the exchanges.  But I suspect that the market listing is not welcomed by the company to begin with so...not likely to happen?   Do I have this right? 

Share
New Message
Please login to post a reply